Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial

Enrolling by invitation · Not applicable

Conditions studied: Bladder Neoplasm

In brief

A robotic assisted surgery for bladder lesion excision.

Key facts

Study ID

NCT06940648

Run by

Virtuoso Surgical, Inc.

People needed

30

Starts

2025-04-17

Expected to finish

2026-09-01

Last updated by the study team

2026-06-29

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject is 22 years or older.
• The subject is eligible and fit for transurethral bladder lesion removal and/or biopsy and has an appropriate indication to go through this surgery.
• The subject is willing and able to provide written informed consent and comply with the study protocol.
• The subject can undergo general anesthesia per anesthesiologist assessment.
• The subject's planned aggregated bladder lesion(s) excision specimens are smaller than 3 cm.

You may not qualify if…

• The subject has acute untreated urinary tract infection or urosepsis.
• The subject has a documented nickel allergy or nickel sensitivity.
• The subject is confirmed to be or suspected to be pregnant.
• The subject is receiving anticoagulants and is unable or not willing to cease the medication for the investigational procedure.
• The subject belongs to a vulnerable group (prisoner, etc.)
• The subject has a urethral abnormality, implant, or previous surgery which would conflict with the procedure.
• The subject has undergone a transurethral bladder resection procedure in the past 6 months.
• The subject has a history of radiation treatment within the pelvis.
• Bladder tumor base maximal dimension is greater than 3 cm.
• Bladder tumor detected during intravesical therapy.
• Previous histological diagnosis different than non-muscle invasive bladder cancer.
• Presence or prior history of upper urinary tract malignancy.
• Eastern Cooperative Oncology Group performance status greater than or equal to 3.
• American Society of Anesthesiologists physical status classification of IV or above.
• History of bleeding disorder, coagulation abnormality, or use of anticoagulants.
• The presence of other active malignancy.
• Life expectancy <1 yr.

Where it is running

• Prince of Wales Hospital, Chinese University of Hong Kong — Hong Kong, Hong Kong, Hong Kong

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.